The National Health Commission and the State Administration of Traditional Chinese Medicine issued the Diagnosis and Treatment Plan for novel coronavirus Infection (Tenth Edition for Trial Implementation) on January 6. What adjustments have been made to the 10th edition of the diagnosis and treatment plan? How to do a good job of diagnosis and treatment "moving forward" and treatment of critical patients? The joint defense and control mechanism of the State Council held a press conference on the 9th to respond to relevant hot issues. The new version of the scheme is optimized and improved according to "Class B and Class B management". "The core idea of the tenth version of the diagnosis and treatment scheme is to manage and treat patients with COVID-19 infection according to the conventional" Class B and Class B "infectious disease management method." Guo Yanhong, director of the Medical Emergency Department of the National Health Commission, said that, first, in terms of treatment measures, cases are no longer required to be treated in isolation; Second, nucleic acid testing is no longer required in the discharge standard. In addition, the program further enriched and optimized the measures and technical means of clinical diagnosis and treatment. At present, medical treatment is a top priority for the prevention and control of the COVID-19 epidemic. Guo Yanhong said that the plan should be optimized from four aspects based on the experience of clinical treatment in China in the past three years. First, strengthen the "gateway forward", early intervention for mild cases, strengthen symptomatic and supportive treatment, and prevent mild cases from turning into severe cases; Second, further standardize the diagnosis and treatment of severe patients and improve relevant early warning indicators; Third, adhere to the combination of traditional Chinese and western medicine; Fourth, strengthen the concept of co treatment of COVID-19 infection and basic diseases, and promote the comprehensive recovery of patients through multidisciplinary consultation. Mi Feng, spokesman of the National Health Commission, said that the diagnosis and treatment work should be carried out in a scientific and standardized manner in strict accordance with the tenth edition of the diagnosis and treatment plan, so as to improve the cure rate and reduce the rate of severe illness and death. After the optimization of the criteria for determining high-risk groups, it is more in line with clinical practice. "At present, the overall pathogenicity of the patients infected with Omixon virus has decreased, but there are still some elderly patients with basic diseases, no vaccination, and low immune function who are prone to severe diseases." Wang Guiqiang, director of the Infectious Diseases Department of the First Hospital of Peking University, said that in order to better guide clinical practice, The tenth edition of the diagnosis and treatment plan defines severe cases of COVID-19 infection as severe cases with pneumonia caused by COVID-19 infection as the main manifestation. The program adjusted the criteria for determining the age of the high-risk groups of severe and critical diseases from more than 60 years old to more than 65 years old. Wang Guiqiang said that this was because it was found in clinical practice that the proportion of people who were over 65 years old with basic diseases and were not vaccinated was higher. However, no matter whether they are older than 60 or 65 years old, the elderly with basic diseases and without vaccination need to carry out early intervention and observation, find problems in time and transfer them to the superior hospital for treatment. The implementation of "gateway forward" focuses on strengthening the targeted treatment of critical diseases by traditional Chinese medicine at the grass-roots level. The grass-roots medical and health institutions play an important role in implementing the "gateway forward" prevention strategy. Li Yongjin, director of Jinsong Community Health Service Center in Chaoyang District, Beijing, said that the center gave full play to the role of family doctors, found out the bottom line, shared the ledger, and identified potential high-risk groups. At the same time, we will closely link up and down with medical consortia hospitals, including general hospitals, establish consultation with experts online, and ensure the green transfer channel offline, so as to ensure the timely treatment of critical patients. "The combination of Chinese and western medicine and the combination of Chinese and western medicine are the unique advantages of epidemic prevention and control in China.